One year follow up study of primary and transitional progressive multiple sclerosis.
about
Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.Clinical characteristics, course and prognosis of spinal multiple sclerosis.Clinical-magnetic resonance imaging correlations in multiple sclerosis.Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.Multiple sclerosis findings in the spinal cord.Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.Sex differences in autoimmune diseases.The emerging role of MRI in multiple sclerosis and the new diagnostic criteria.Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportSpinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year studyPurkinje cell loss in experimental autoimmune encephalomyelitis.Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis.Workshop on primary progressive multiple sclerosis: meeting summary.Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability.Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.Two-year follow-up study of primary and transitional progressive multiple sclerosis.Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.Cervical spinal cord atrophy: An early marker of progressive MS onset.Brain atrophy in clinically early relapsing-remitting multiple sclerosis.The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.Current developments in MRI for assessing rodent models of multiple sclerosisA longitudinal study of cognition in primary progressive multiple sclerosis
P2860
Q30983016-6BCD07CB-1146-4374-A6F3-5772B0C96EEBQ30989935-013FA973-449A-4123-AEF8-53D0B69702C4Q30993916-D1057EE7-D63C-4B03-B721-1B06AD0C1CD4Q31027945-E4F542EF-1F7E-45B5-A20F-85D35FD6DDA5Q31037055-3D8AAD91-A988-48FA-81F1-6925EDEED138Q31128783-A3E2FF48-40F0-4695-A43E-07D3C1E7764EQ34437540-1C6F0D6B-50D1-4422-A88D-F99F23C04609Q34498866-44AD9D21-3F1F-49BB-92ED-F9CE96E993A7Q34590306-0BD0E05F-0E6B-4904-B517-574343B65ED1Q35471656-7D6CAE5A-1B53-4EFB-AAA8-F95BBF8B889AQ35472473-96CF2E6F-8A00-4160-9611-EF4DA0851F58Q35475689-8957D781-385F-4F17-826F-CDADB8CBF01EQ35818129-6273EFAE-08F3-4C4F-BECA-42A5121CDD01Q35965843-B0331C35-2F73-47D4-B623-12D490D13258Q36143320-CF9DA0C5-0460-48F2-AD0A-D71E64D04765Q36226297-90966111-AF7F-4E9B-80FF-9F469CC62705Q37368941-8D225BF7-B0CC-4482-84A6-FD7F66121F85Q38672618-5C73474E-4805-400E-A7C3-483AB2ABCBD1Q40997871-812FE730-92A9-48F1-BA87-02D37082B1C6Q43980191-111951A3-D984-4B72-B9F4-15689F38D567Q47237680-78BD03A8-127F-42FD-B8E4-5BC5FD3EACA8Q48134359-8BC0F4C4-EE21-4312-88E0-B2208BC3E4D6Q48384914-98EB19EF-AA97-47AE-A724-DB6DD4EE1D60Q48615365-81F2280F-E633-4942-B716-3479D2AA62CBQ48690785-6F820C86-9F70-4777-AC22-47F8C58E426EQ49760918-21CA4B53-3FC7-4C9A-92FE-7B24C8A15BC9Q52046432-E845336C-17A5-4048-A7FC-CDECE3C6586AQ52072205-E07DF7D1-C8C8-4EB1-9C80-B7F5B26D52ABQ53455681-7D4078AC-43B7-416E-BBA6-014A57E3D5CCQ57521580-D952E011-F75F-483C-B768-9EB294995918Q57911892-D42AC5F3-4FA8-4379-8513-18BF496264DC
P2860
One year follow up study of primary and transitional progressive multiple sclerosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
One year follow up study of primary and transitional progressive multiple sclerosis.
@en
One year follow up study of primary and transitional progressive multiple sclerosis.
@nl
type
label
One year follow up study of primary and transitional progressive multiple sclerosis.
@en
One year follow up study of primary and transitional progressive multiple sclerosis.
@nl
prefLabel
One year follow up study of primary and transitional progressive multiple sclerosis.
@en
One year follow up study of primary and transitional progressive multiple sclerosis.
@nl
P2093
P2860
P356
P1476
One year follow up study of primary and transitional progressive multiple sclerosis.
@en
P2093
A J Thompson
C H Polman
D H Miller
P2860
P304
P356
10.1136/JNNP.68.6.713
P407
P577
2000-06-01T00:00:00Z